NCT06722807
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,098 public trials
1,201 recruiting studies
Adenocarcinoma trial results
Suspended
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
NCT03077841
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +21 more
- Locations
-
- Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
- Piedmont Hospital Atlanta, Georgia, United States
- Community Cancer Center East Indianapolis, Indiana, United States
- Covenant Medical Center Harrison Saginaw, Michigan, United States
NCT07181720
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Thyroid Carcinomas, +43 more
- Locations
-
- The 901 Hospital of Joint Logistics Support Force of People Liberation Army Hefei, Anhui, China
NCT06868238
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +10 more
- Locations
-
- University of Florida Gainesville, Florida, United States
NCT06671912
- Conditions
- Adenocarcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, +18 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
NCT04669860
- Conditions
- Adenocarcinoma, Calcium Oxalate Urolithiasis, Carcinoma, +16 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT05791448
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, +15 more
- Locations
-
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Withdrawn
Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
NCT07365839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified